Biomerica, Inc.
BMRA
$0.5725
-$0.0315-5.22%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.40% | 5.49% | 0.72% | -8.46% | 5.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.40% | 5.49% | 0.72% | -8.46% | 5.74% |
| Cost of Revenue | -3.46% | 16.68% | 1.58% | 17.66% | 9.91% |
| Gross Profit | 34.46% | -29.85% | -31.03% | -224.17% | -7.67% |
| SG&A Expenses | -22.88% | 16.04% | -14.24% | 9.35% | -2.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.20% | 7.81% | -10.19% | 9.23% | 0.86% |
| Operating Income | 38.25% | -11.04% | 16.78% | -21.14% | 3.48% |
| Income Before Tax | 36.42% | -18.30% | 20.52% | -18.51% | 7.75% |
| Income Tax Expenses | -137.50% | -82.61% | -46.15% | -88.57% | 700.00% |
| Earnings from Continuing Operations | 36.96% | -16.25% | 20.70% | -16.24% | 7.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.96% | -16.25% | 20.70% | -16.24% | 7.32% |
| EBIT | 38.25% | -11.04% | 16.78% | -21.14% | 3.48% |
| EBITDA | 38.93% | -11.23% | 17.16% | -21.25% | 3.46% |
| EPS Basic | 38.06% | -16.20% | 21.76% | 6.86% | 25.83% |
| Normalized Basic EPS | 37.52% | -18.20% | 21.64% | 5.07% | 26.23% |
| EPS Diluted | 33.33% | -14.29% | 16.67% | 6.86% | 25.50% |
| Normalized Diluted EPS | 37.52% | -18.20% | 21.64% | 5.07% | 26.23% |
| Average Basic Shares Outstanding | 1.78% | 0.00% | 1.37% | 24.78% | 25.02% |
| Average Diluted Shares Outstanding | 1.78% | 0.00% | 1.37% | 24.78% | 25.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
